Etiket: #covid19#bilim insanlari #hastalik #asi #guc

2BEHRJJ (200414) -- BEIJING, April 14, 2020 (Xinhua) -- A staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing, capital of China, March 16, 2020. China has approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council joint prevention and control mechanism against the coronavirus Tuesday. The two vaccine candidates are developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group (Sinopharm) and Sinovac Research and Development Co., Ltd, a company based in Beijing. Clinical

COVİD-19

Merhaba ben Defne bugün 2020 yılında hayatımıza giren ve hala devam eden covid-19 hakkında konuşacağız. 2020 yılından beri hayatımızda olan covid-19 Çin’in başkenti Wuhan’da ortaya […]

Devamını oku